AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2016

Jun 15, 2016

31071_dirs_2016-06-15_4dab301f-9080-49b9-8efd-bafded2fa333.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2016-06-13

Reporting Person: Ferrari Mauro (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-13	Common Stock	A	8517	$0.00	Acquired	12768	Direct

Footnotes

F1: Dr. Ferrari has historically declined to accept cash or equity compensation for his service based on the previous policies of his employer. During 2016, the policies of his employer changed to allow certain other compensation. This award represents compensation for his services performed during fiscal 2016.